Author

Kata Szántó 1

1 University of Szeged,Szeged,Hungary

CHARACTERISTICS OF ANTI-TNF ALPHA THERAPY FOR ULCERATIVE COLITIS BETWEEN 2010-2016 IN HUNGARY

Anita Balint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Péter Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Tamás Molnár

DOES ANY CONNECTION EXIST BETWEEN BLOOD THIOPURINE LEVEL AND ANTI TNF DRUG LEVEL OR BODY COMPOSITION PARAMETERS - A CROSS-SECTIONAL STUDY IN A HUNGARIAN IBD CENTRE

Kata Szántó, Anna Fabian, András Lajos Szíjártó, Imre Földesi, Diána Kata, Zoltán András Mezei, Anita Balint, Renáta Bor, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Zoltan Gabor Szepes, Ferenc Nagy, Tamás Bubán, Szilvia Lovas, Karoly Palatka, Tamás Molnár

DOES ANY CONNECTION EXIST BETWEEN BLOOD THIOPURINE LEVEL AND ANTI TNF DRUG LEVEL OR BODY COMPOSITION PARAMETERS – A CROSS-SECTIONAL STUDY IN A HUNGARIAN IBD CENTRE

Kata Szántó

ENDOSCOPIC ULTRASOUND GUIDED FINE-NEEDLE ASPIRATION OF RECTAL AND PERIRECTAL LESIONS

Anna Fabian, Renáta Bor, Béla Vasas, Sándor Hamar, László Tiszlavicz, Anita Balint, László Czakó, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Kata Szántó, Tamás Molnár, Zoltán Szepes

EPIDEMIOLOGY, INCIDENCE OF COLORECTAL CANCER, MORTALITY AND THE USE OF BIOLOGICAL THERAPY IN ULCERATIVE COLITIS PATIENTS BETWEEN 2007-2016 IN HUNGARY

Tamás Molnár, Ágnes Milassin, Kata Szántó, Pater Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Klaudia Farkas

Fecal concentration of vedolizumab correlates with tissue drug levels and endoscopic activity in inflammatory bowel disease patients

Klaudia Farkas, Kata Szántó, Diána Kata, Imre Földesi, Tibor Nyári, Fanni Balogh, Mariann Rutka, Anita Balint, Renáta Bor, Anna Fabian, Ágnes Milassin, Zoltan Gabor Szepes, Ferenc Nagy, József Maléth, Tamás Molnár

Fecal microbiota composition of ulcerative colitis patents after restorative proctocolectomy with ileal pouch-anal anastomisis- comparative, prospective study from Hungary

Anita Balint, Klaudia Farkas, Bálint Kintses, Orsolya Méhi, Tamara Madacsy, József Maléth, Kata Szántó, Mariann Rutka, Péter Bacsur, Zoltan Gabor Szepes, Ferenc Nagy, Anna Fabian, Renáta Bor, Tamás Molnár

LONG-TERM EFFICACY OF VEDOLIZUMAB THERAPY ON CLINICAL AND ENDOSCOPIC ACTIVITY IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR ALPHA RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Zoltan Gabor Szepes, Mária Matuz, Klaudia Farkas, Anna Fabian, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Lilla Laura Lakner, Katalin Müllner, Mária Papp, Ágnes Szabone Dr Salamon, Eszter Schäfer, Krisztina Fülöpné Sarang, Ferenc Nagy, Ferenc Zsigmond, János Banai, Kata Szántó, Anita Balint, M

Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and fecal calprotectin concentrations in inflammatory bowel diseases patients

Kata Szántó, Klaudia Farkas, Diána Kata, Viktor Tóth, Anita Balint, Ágnes Milassin, Anna Fabian, Renáta Bor, Mariann Rutka, Zoltan Gabor Szepes, István Soós, Ferenc Nagy, Imre Földesi, Tamás Molnár

Retrospective comparison of efficacy and cost-effectiveness of self-expandable metal stents and plastic biliary stents in the management of malignant biliary obstruction

Renáta Bor, Anna Fabian, Klaudia Farkas, Tibor Tóth, Kata Szántó, Anita Balint, Ágnes Milassin, László Czakó, Tamás Molnár, Mónika Szűcs, Mariann Rutka, Zoltan Gabor Szepes

Item 1 - 10 / 13
1
2